Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)

NCT ID: NCT03009279

Last Updated: 2017-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the association between metabolic syndrome (MS) and thyroid nodule(s).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To investigate the association between metabolic syndrome (MS), body mass index (BMI), hyperglycemia, dyslipidemia, hypertension and thyroid nodule(s) or thyroid functions in euthyroid subjects. Screen for the risk factors that affect the incidence of thyroid nodule(s).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome Thyroid Nodule

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The MS group

Patients with metabolic syndrome(MS).

No interventions assigned to this group

The non-MS group

Patients without metabolic syndrome(MS).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. People who received routain physical and laboratory examinations in the Health Management Cenre of QianFoShan Hospital from Jan. 2013 to Dec. 2015.
2. signed the informed consent.
3. Have complete clinical data.

Exclusion Criteria

1. Patients with previous history of thyroid disease other than thyroid nodules.
2. People with abnormal thyroid function.
3. Thyroid ultrasound revealed patients with other lesions other than normal thyroid and thyroid nodules.
4. Pregnant or lactating women.
Minimum Eligible Age

15 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lin Liao

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lin Liao

chief of endocrinology department at Qianfoshan Hospital

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lin Liao

Role: STUDY_CHAIR

Qianfoshan Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lin Liao, MD

Role: CONTACT

8615168888260

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

qfsnfm-004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

SUMCO Metabolic Syndrome Project
NCT01278628 COMPLETED PHASE1